Increasing popularity of effective medications like beta-blockers, antiplatelet drugs, and statins is expected to drive critical limb ischemia treatment market growth.Wilmington, Delaware, United States, July 24, 2023 (GLOBE NEWSWIRE) The global critical limb ischemia treatment market is anticipated to grow at 8.03 % CAGR from 2023 to 2031. A market valuation of US$ 3.49 billion by 2031. The demand for critical limb ischemia therapeutics is expected to rise due to increasing prevalence of hyp
Efficacy of triclabendazole for treatment of liver fluke at various stages of the infection is augmenting triclabendazole market growthWilmington, Delaware, United States, July 19, 2023 (GLOBE NEWSWIRE) The global triclabendazole market stood at US$ 412.0 Mn in 2020 and is projected to grow at a CAGR of 4.1% during the forecast period from 2021 to 2031. Increase in incidence of liver fluke and efficacy of triclabendazole for treatment of the disease from the very early stage to mature stage a
Growing focus on women’s healthcare is a major factor that is anticipated to escalate the cervical cancer diagnostic tests market growth. Favorable reimbursement policies, is another factor that is anticipated to stimulate the market share in the coming yearsWilmington, Delaware, United States, July 06, 2023 (GLOBE NEWSWIRE) The global cervical cancer diagnostic tests market stood at US$ 8.7 billion in 2021, and the global market is projected to reach US$ 13.6 billion by 2031. The global indu
Wilmington, Delaware, United States, July 04, 2023 (GLOBE NEWSWIRE) The global liquid filled hard capsules market stood at US$ 2.3 billion in 2021, and the global market is projected to reach US$ 4.0 billion by
The rise in the prevalence of anxiety-related illnesses is increasing the demand for benzodiazepine APIs, which are often given to treat anxiety symptoms. Furthermore, ongoing study and development activities are targeted at increasing benzodiazepine administration and effectiveness.Wilmington, Delaware, United States, June 22, 2023 (GLOBE NEWSWIRE) In 2022, the benzodiazepine APIs market was estimated to be worth US$ 472.8 million. It is expected to grow at a 3.6% CAGR from 2023 to 2031, rea